大流行防范工具可以通过在集中化和去中心化之间取得平衡来优化抗菌素耐药性治理格局。
A Pandemic Instrument can Optimize the Regime Complex for AMR by Striking a Balance between Centralization and Decentralization.
机构信息
YORK UNIVERSITY, TORONTO, ONTARIO, CANADA.
出版信息
J Law Med Ethics. 2022;50(S2):26-33. doi: 10.1017/jme.2022.76.
Abstract
Global antimicrobial resistance (AMR) is currently governed by a decentralized regime complex composed of multiple institutions with overlapping and sometimes conflicting principles, norms, rules, and procedures. Such a decentralized regime complex provides certain advantages and disadvantages when compared to a centralized regime. A pandemic instrument can optimize the regime complex for AMR by leveraging the strengths of both centralization and decentralization. Existing climate treaties under the UNFCCC offer lessons for achieving this hybrid approach.
摘要
全球抗菌药物耐药性（AMR）目前由一个去中心化的制度体系所治理，该体系由多个机构组成，它们的原则、规范、规则和程序存在重叠和冲突。与集中化的制度体系相比，这种去中心化的制度体系具有一定的优势和劣势。大流行应对工具可以通过利用集中化和去中心化的优势，来优化 AMR 的制度体系。《联合国气候变化框架公约》下的现有气候条约为实现这种混合方法提供了经验教训。
相似文献
1
A Pandemic Instrument can Optimize the Regime Complex for AMR by Striking a Balance between Centralization and Decentralization.大流行防范工具可以通过在集中化和去中心化之间取得平衡来优化抗菌素耐药性治理格局。
J Law Med Ethics. 2022;50(S2):26-33. doi: 10.1017/jme.2022.76.
2
Centralization vs. Decentralization in COVID-19 Responses: Lessons from China.新冠疫情应对中的集中化与去中心化：来自中国的经验教训
J Health Polit Policy Law. 2022 Jun 1;47(3):411-427. doi: 10.1215/03616878-9626908.
3
AMR Belongs in the Pandemic Instrument.抗菌药物耐药性应纳入大流行应对工具。
J Law Med Ethics. 2022;50(S2):6-8. doi: 10.1017/jme.2022.73.
4
Centralizing and decentralizing governance in the COVID-19 pandemic: The politics of credit and blame.在 COVID-19 大流行中集中和分散治理：信用和责任的政治。
Health Policy. 2022 May;126(5):408-417. doi: 10.1016/j.healthpol.2022.03.004. Epub 2022 Mar 11.
5
The role of climate change and decentralization in urban water services: A dynamic energy-water nexus analysis.气候变化和权力下放在城市水服务中的作用：动态能源-水关联分析。
Water Res. 2021 Dec 1;207:117830. doi: 10.1016/j.watres.2021.117830. Epub 2021 Nov 1.
6
Unprecedented Challenges, Familiar Paradoxes: COVID-19 and Governance in a New Normal State of Risks.前所未有的挑战，似曾相识的悖论：新冠疫情与风险新常态下的治理
Public Adm Rev. 2020 Jul-Aug;80(4):657-664. doi: 10.1111/puar.13248. Epub 2020 Jun 29.
7
Centralization and integration of public health systems: Perspectives of public health leaders on factors facilitating and impeding COVID-19 responses in three Canadian provinces.公共卫生系统的集中化和整合：三位加拿大省级公共卫生领导人对促进和阻碍 COVID-19 应对措施的因素的看法。
Health Policy. 2023 Jan;127:19-28. doi: 10.1016/j.healthpol.2022.11.011. Epub 2022 Nov 23.
8
Decentralization or centralization: striking a balance.分权还是集权：寻求平衡。
Nurs Manage. 1994 Sep;25(9):49-51.
9
What supervisors want to know about decentralization.管理者想了解的关于权力下放的内容。
Health Care Superv. 1991 Jun;9(4):59-70.
10
Punt Politics as Failure of Health System Stewardship: Evidence from the COVID-19 Pandemic Response in Brazil and Mexico.将政治视为卫生系统管理失败：来自巴西和墨西哥应对新冠疫情的证据
Lancet Reg Health Am. 2021 Dec;4:100086. doi: 10.1016/j.lana.2021.100086. Epub 2021 Sep 27.
引用本文的文献
1
Forum shifting in global health security.全球卫生安全中的论坛转变
Bull World Health Organ. 2024 Feb 1;102(2):123-129. doi: 10.2471/BLT.23.290480. Epub 2023 Oct 31.
本文引用的文献
1
A 'whole of United Nations approach' to tackle antimicrobial resistance? A mapping of the mandate and activities of international organisations.采取“联合国整体办法”防治抗微生物药物耐药性？ 对国际组织的任务和活动进行的制图。
BMJ Glob Health. 2022 May;7(5). doi: 10.1136/bmjgh-2021-008181.
2
Governing Global Antimicrobial Resistance: 6 Key Lessons From the Paris Climate Agreement.治理全球抗微生物药物耐药性：从《巴黎气候协定》中汲取的6个关键教训。
Am J Public Health. 2022 Apr;112(4):553-557. doi: 10.2105/AJPH.2021.306695.
3
A Global Pandemic Treaty Must Address Antimicrobial Resistance.全球大流行病条约必须解决抗微生物药物耐药性问题。
J Law Med Ethics. 2021;49(4):688-691. doi: 10.1017/jme.2021.94.
4
Global COVID-19 vaccine inequity: The scope, the impact, and the challenges.全球新冠疫苗不平等：范围、影响及挑战
Cell Host Microbe. 2021 Jul 14;29(7):1036-1039. doi: 10.1016/j.chom.2021.06.007.
5
The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement.知识产权在世界卫生组织非洲区域获得药品方面的作用：《与贸易有关的知识产权协定》通过 25 年后。
BMC Public Health. 2021 Mar 11;21(1):490. doi: 10.1186/s12889-021-10374-y.
6
Exploring Models for an International Legal Agreement on the Global Antimicrobial Commons: Lessons from Climate Agreements.探索关于全球抗菌共用物的国际法律协议模式：气候协议的经验教训。
Health Care Anal. 2023 Mar;31(1):25-46. doi: 10.1007/s10728-019-00389-3.
7
Knowledge, moral claims and the exercise of power in global health.知识、道德主张与全球卫生中的权力行使。
Int J Health Policy Manag. 2014 Nov 8;3(6):297-9. doi: 10.15171/ijhpm.2014.120. eCollection 2014 Nov.
Zotero 插件